Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China
· Delayed Price · Currency is CNY 13.99
+0.06 (0.43%)
Apr 30, 2026, 1:45 PM CST
SHE:002907 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 5,817 | 6,185 | 5,429 | 6,452 | 8,502 | 7,250 | Upgrade
|
| Market Cap Growth | -0.50% | 13.92% | -15.86% | -24.12% | 17.27% | 34.50% | Upgrade
|
| Enterprise Value | 5,211 | 5,651 | 4,957 | 5,999 | 8,261 | 6,982 | Upgrade
|
| Last Close Price | 13.93 | 14.81 | 12.94 | 15.28 | 20.04 | 17.70 | Upgrade
|
| PE Ratio | 89.35 | 95.02 | 70.75 | 197.31 | 86.41 | 79.00 | Upgrade
|
| PS Ratio | 7.03 | 7.48 | 7.01 | 9.33 | 10.83 | 8.57 | Upgrade
|
| PB Ratio | 3.41 | 3.62 | 3.27 | 3.99 | 5.28 | 5.73 | Upgrade
|
| P/TBV Ratio | 3.93 | 4.17 | 3.54 | 4.27 | 5.54 | 6.10 | Upgrade
|
| P/FCF Ratio | 122.00 | 129.70 | 37.28 | 50.99 | - | 276.62 | Upgrade
|
| P/OCF Ratio | 93.46 | 99.37 | 33.56 | 29.42 | 651.77 | 87.51 | Upgrade
|
| EV/Sales Ratio | 6.30 | 6.83 | 6.40 | 8.67 | 10.52 | 8.25 | Upgrade
|
| EV/EBITDA Ratio | 37.47 | 40.80 | 33.55 | 54.69 | 47.99 | 42.39 | Upgrade
|
| EV/EBIT Ratio | 98.69 | 107.03 | 81.39 | 215.92 | 84.65 | 73.53 | Upgrade
|
| EV/FCF Ratio | 109.29 | 118.52 | 34.04 | 47.41 | - | 266.38 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0 | 0 | 0 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 1.52 | Upgrade
|
| Debt / FCF Ratio | 0.08 | 0.08 | 0.00 | 0.00 | - | 9.58 | Upgrade
|
| Net Debt / Equity Ratio | -0.36 | -0.36 | -0.37 | -0.30 | -0.31 | -0.20 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.49 | -4.49 | -4.11 | -4.44 | -2.92 | -1.57 | Upgrade
|
| Net Debt / FCF Ratio | -13.04 | -13.04 | -4.17 | -3.85 | 10.58 | -9.90 | Upgrade
|
| Asset Turnover | 0.42 | 0.42 | 0.41 | 0.37 | 0.43 | 0.48 | Upgrade
|
| Inventory Turnover | 2.54 | 2.54 | 2.28 | 2.35 | 2.65 | 3.26 | Upgrade
|
| Quick Ratio | 3.47 | 3.47 | 4.17 | 3.91 | 3.92 | 3.64 | Upgrade
|
| Current Ratio | 4.27 | 4.27 | 4.86 | 4.74 | 4.53 | 4.32 | Upgrade
|
| Return on Equity (ROE) | 3.28% | 3.28% | 4.68% | 2.03% | 6.84% | 7.50% | Upgrade
|
| Return on Assets (ROA) | 1.67% | 1.67% | 2.02% | 0.93% | 3.35% | 3.40% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.36% | 3.52% | 4.58% | 1.90% | 8.39% | 8.85% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.00% | 3.00% | 3.60% | 1.70% | 5.90% | 6.10% | Upgrade
|
| Earnings Yield | 1.12% | 1.05% | 1.41% | 0.51% | 1.16% | 1.27% | Upgrade
|
| FCF Yield | 0.82% | 0.77% | 2.68% | 1.96% | -0.56% | 0.36% | Upgrade
|
| Dividend Yield | 0.54% | 0.51% | 0.66% | 0.33% | 0.35% | 0.28% | Upgrade
|
| Payout Ratio | 54.54% | 54.54% | 46.26% | 92.25% | 23.42% | 14.60% | Upgrade
|
| Buyback Yield / Dilution | 0.05% | 0.05% | -0.02% | -3.60% | -0.49% | -0.06% | Upgrade
|
| Total Shareholder Return | 0.77% | 0.55% | 0.64% | -3.27% | -0.14% | 0.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.